Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A pneumonia outbreak associated with a new coronavirus of probable bat origin

(2020) Peng Zhou et al.   NATURE

Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19)

(2020) Kaijin Xu et al.   CLINICAL INFECTIOUS DISEASES

Risk Factors for Viral RNA Shedding in COVID-19 Patients

(2020) Yu Fu et al.   EUROPEAN RESPIRATORY JOURNAL

Factors associated with duration of viral shedding in adults with COVID-19 outside of Wuhan, China: A retrospective cohort study

(2020) Lin Qi et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

SARS-CoV-2 RNA polymerase as target for antiviral therapy

(2020) Luigi Buonaguro et al.   Journal of Translational Medicine

COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)

(2020) Yang Song et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Clearance and persistence of SARS‐CoV‐2 RNA in patients with COVID‐19

(2020) Anália Carmo et al.   JOURNAL OF MEDICAL VIROLOGY

An Early Test-and-Treat Strategy for Severe Acute Respiratory Syndrome Coronavirus 2

(2020) Joshua T Schiffer et al.   Open Forum Infectious Diseases

A prospective, randomized, open-label trial of early versus late favipiravir in hospitalized patients with COVID-19

(2020) Yohei Doi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19

(2020) Christoph D. Spinner et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response

(2020) Ashish Goyal et al.   Science Advances

Favipiravir as a potential countermeasure against neglected and emerging RNA viruses

(2018) Leen Delang et al.   ANTIVIRAL RESEARCH

Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase

(2017) Yousuke FURUTA et al.   PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES

Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data

(2016) Carl J Heneghan et al.   HEALTH TECHNOLOGY ASSESSMENT

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

(2013) Yousuke Furuta et al.   ANTIVIRAL RESEARCH